Stockholders' Equity - Additional Information (Details) - USD ($)	4 Months Ended	12 Months Ended
	Apr. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	May 31, 2023	Jan. 31, 2023
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Dividends declared		$ 0
Common stock, voting rights		Each share of common stock entitles the holder to one vote and to receive dividends when and if declared by the board of directors of the Company.
Increase in number of shares of preferred stock, percentage		19.99%
Number of shares of common stock, percentage		9.99%
Preferred stock, par value		$ 0.0001	$ 0.0001
Shares sold/issued		58,510,610	42,900,083
Losses attributed to noncontrolling interests		$ (192,000)	$ (1,939,000)
2024 Private Placement
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Shares sold/issued	14,400,000
Warrants Issued to Purchase Additional Common Shares	300,000
Net Cash Proceeds from 2024 Private Placement	$ 262,700
Deferred offering costs	$ 17,300,000
Warrant
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Exercise price		$ 0.001
Additional shares issued		300,000
In May 2023
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Offer and sell companys common stock				$ 125,000,000
In May 2023 | At The Market Equity Offering Program
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Treasury Stock, Common, Shares		85,600,000
Net proceeds		$ 38,400,000
Shares sold/issued		3,300,000
Biotechnology Value Fund, L.P exchange agreement [Member]
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Preferred stock, par value					$ 0.0001
Number of common stock exchange					6,500,000
Newly designated Series A preferred stock					600,000
Cullinan M I C A Corp [Member]
Common Stock And Noncontrolling Interest In Subsidiaries [Line Items]
Losses attributed to noncontrolling interests		$ 4,400,000